Even though OCD cannot be completely cured, bringing the symptoms of OCD (Obsessive Compulsive...
From The Desk Of Dr. Paresh Doshi
A recent study conducted by University of California team examined the cost effectivity of Deep Brain Stimulation (DBS) in comparison to the best medical treatment in USA. A decision-analytic state-transition (Markov) model to project PD progression and associated costs for the two treatment strategies was used. The discounted incremental cost-effectiveness ratio (ICER) in U.S. dollars per quality-adjusted life-year (QALY) from the Medicare payer perspective, considering a ten-year horizon, and evaluated the robustness of projections through extensive deterministic sensitivity analyses was estimated.
They found that, over ten years, DBS treatment led to discounted total costs of $130,510 compared to $91,026 for BMT and added 1.69 QALYs more than BMT, resulting in an ICER of $23,404 per QALY. This ICER was relatively insensitive to variations in input parameters, with neurostimulator replacement, costs for DBS implantation, and costs for treatment of disease-related falls having the greatest effects. Across all investigated scenarios, including a five-year horizon, ICERs remained under $50,000 per QALY. Longer follow-up periods and younger treatment age were associated with greater cost-effectiveness.
DBS is a cost-effective treatment strategy for advanced PD in the U.S. healthcare system across a wide range of assumptions. DBS yields substantial improvements in health-related quality of life at a value profile that compares favorably to other well-accepted therapies.
Book An Appointment
"- Times of India , Mumbai
UK national goes under knife in city to cure rare headaches."
"- DNA , Mumbai
City docs give man with Parkinson’s his life back."
"- Times of India , Mumbai
Now, brain device cell for neuro patients lasts 25 years."
"- Times of India , Indore
Brain disorders curable with surgery."
"- Times of India , Ahmedabad
Remote control miraculously mutes Parkinson’s afflictions."
Success rate in safe hands is more than 95%. Complications in the form of post-operative transient neurodeficits can occur in 2-5%. Mortality in modern neurosurgery in expert hands approaches to zero.
Surgery is helpful for relieving tremors, drug induced side effect leading to involuntary movements called dyskinesia, frequent on-off fluctuations, prolonged off periods, pain, dystonia (curling of fingers and toes), postural imbalance, severe rigidity, hallucinations, etc. In short any patient:
- Who is not satisfied with his/her level of control of Parkinson’s disease.
- Exhibits Parkinson’s disease symptoms causing a decline in the quality of life
- Has had an adequate and reasonable trial of medications is a candidate for surgery.
I had DBS performed, but have not obtained relief, is there a scope of improvement by reprogramming?
From the Blog
Parkinson’s disease is caused by the gradual degeneration of nerve cells in the midbrain...